WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced that it plans to report its fiscal fourth quarter and year ended September 30, 2014 financial results before the U.S. markets open on November 24, 2014. Enanta management will host a conference call at 8:30 a.m. ET to discuss these results and to provide an update on its research and development pipeline.
Help employers find you! Check out all the jobs and post your resume.
